Curtis A. Engelhart

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis”.

Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis

EMBO Molecular Medicine(2020)10.15252/emmm.202013207

N/A

2.0DataRank · unranked

98 citations

Kiel Hards, Curtis A. Engelhart, Erik Hasenoehrl, Nitin Pal Kalia, Jared S. Mackenzie +16 more

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c01586

N/A

0.546DataRank · unranked

37 citations

Peter C. Ray, Fabio Zuccotto, Jorge Hernández, Anup Aggarwal, Claire J. Mackenzie +35 more

SuFEx-based antitubercular compound irreversibly inhibits Pks13

Nature(2025)10.1038/s41586-025-09286-3

N/A

0.457DataRank · unranked

20 citations

Paridhi Sukheja, Baiyuan Yang, Su Tang, Daniel Selle, Ashley Woods +40 more

Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of Mycobacterium tuberculosis

ACS Infectious Diseases(2025)10.1021/acsinfecdis.4c00808

N/A

0.241DataRank · unranked

4 citations

Justin R. Harrison, Stephen Thompson, Dinakaran Murugesan, M. Daben J. Libardo, Curtis A. Engelhart +18 more

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Nature Microbiology(2022)10.1038/s41564-022-01130-y

N/A

0DataRank · unranked

234 citations

Nicholas C. Poulton, Jesseon S. Chang, Zachary A. Azadian, Michael A. DeJesus, Nadine Ruecker +10 more

Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

Nature Communications(2022)10.1038/s41467-022-33736-5

N/A

0DataRank · unranked

34 citations

Susan H. Davis, Sebastian Damerow, Curtis A. Engelhart, Michael Mathieson, Beatriz Baragaña +40 more

Two‐way regulation of protein expression for identification and validation of on‐target inhibitors of Mycobacterium tuberculosis

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.l7723

N/A

0DataRank · unranked

0 citations

Curtis A. Engelhart, Esther Perez‐Herran, Divya Tiwari, Wei Li, Katherine A. Abrahams +9 more

Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity

Figshare(2022)10.5281/zenodo.6533839

N/A

0DataRank · unranked

0 citations

Rudolf Müller, Kawaljit Singh, Virsinha Reddy, Charles J. Eyermann, Stephen E. Fienberg +12 more

Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c01514

N/A

0DataRank · unranked

21 citations

Caroline Wilson, T.C. Eadsforth, Avinash S. Punekar, Fábio K. Tamaki, Gavin Wood +18 more

Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in Mycobacterium tuberculosis

mBio(2023)10.1128/mbio.00340-23

N/A

0DataRank · unranked

10 citations

Travis Hartman, Tiago Beites, Jeehyun Kim, Hyungjin Eoh, Curtis A. Engelhart +7 more

Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors

ACS Infectious Diseases(2025)10.1021/acsinfecdis.5c00394

N/A

0DataRank · unranked

6 citations

R. H. Allen, Helena I. Boshoff, Laura A. T. Cleghorn, Curtis A. Engelhart, Dirk Schnappinger +2 more

Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial Agents

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c02299

N/A

0DataRank · unranked

0 citations

Curtis A. Engelhart, Joshua B. Wallach, Divya Tiwari, Peng Ge, Adhar C. Manna +14 more

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

ACS Omega(2021)10.1021/acsomega.0c05589

N/A

0DataRank · unranked

33 citations

Margaret Huggett, Penelope A. Turner, Malcolm Taylor, Laura A. T. Cleghorn, Julie V. Early +32 more

Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.0c01727

N/A

0DataRank · unranked

21 citations

Vinayak Singh, Alissa Myrick, Sandile B. Simelane, Dale Taylor, Christel Brunschwig +21 more

A chemical-genetic map of the pathways controlling drug potency in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.27.469863

N/A

0DataRank · unranked

4 citations

Nicholas C. Poulton, Jesseon S. Chang, Zachary A. Azadian, Michael A. DeJesus, Nadine Ruecker +10 more